It is generally recommended that Tegretol be used for at least 12 months after stent placement. Specific medication should be prescribed by your doctor.
Tegretol is a commonly used first-line antiplatelet drug after stent placement, which can block platelet adhesion and aggregation in blood vessels, and prevent and reduce the risk of thrombosis after stent placement. The Chinese Expert Consensus on Clinical Application of Tegretol states that Tegretol should be used for at least 12 months after stenting.
However, when taking Tegretol orally on a daily basis, it is important to pay attention to any adverse reactions, such as dyspnea and bleeding. Some patients may experience dyspnea and chest tightness after taking Tegretol orally, which is a common adverse reaction to Tegretol. If the symptoms are mild and tolerable, they can be observed first, and if the symptoms are gradually relieved, the treatment with this drug can be continued. It is contraindicated if you are allergic to this product.
In addition, there is a risk of bleeding in the application of Tegretol, which needs to be decided according to the location and degree of bleeding, if the bleeding area is large, it is recommended to consult a doctor in time, make a treatment plan under the guidance of specialists, and follow the doctor’s instructions.